Large deletions induced by Cas9 cleavage-Reference-Cited by-同舟云学术

Large deletions induced by Cas9 cleavage

Published:2018-08 Issue:7717 Volume:560 Page:E8-E9
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Adikusuma Fatwa,Piltz Sandra,Corbett Mark A.,Turvey Michelle,McColl Shaun R.,Helbig Karla J.,Beard Michael R.,Hughes James,Pomerantz Richard T.,Thomas Paul Q.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-018-0380-z.pdf

Reference8 articles.

1. Ma, H. et al. Correction of a pathogenic gene mutation in human embryos. Nature 548, 413–419 (2017).

2. Wang, H. et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153, 910–918 (2013).

3. Chen, J. et al. Efficient detection, quantification and enrichment of subtle allelic alterations. DNA Res. 19, 423–433 (2012).

4. Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protocols 8, 2281–2308 (2013).

5. Shin, H. Y. et al. CRISPR/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome. Nat. Commun. 8, 15464 (2017).

Cited by 298 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering probiotic Escherichia coli Nissle 1917 to block transfer of multiple antibiotic resistance genes by exploiting a type I CRISPR-Cas system;Applied and Environmental Microbiology;2024-09-10

2. Targeted knock-in of NCF1 cDNA into the NCF2 locus leads to myeloid phenotypic correction of p47 -deficient chronic granulomatous disease;Molecular Therapy - Nucleic Acids;2024-09

3. Immunosuppressant therapy averts rejection of allogeneic FKBP1A-disrupted CAR-T cells;Molecular Therapy;2024-09

4. A long noncoding RNA at the cortex locus controls adaptive coloration in butterflies;Proceedings of the National Academy of Sciences;2024-08-30

5. Gene Editing of the Endogenous Cryptic 3′ Splice Site Corrects the RNA Splicing Defect in the β⁶⁵⁴-Thalassemia Mouse Model;Human Gene Therapy;2024-08-13